Concord Medical Services (NYSE:CCM) and LifeStance Health Group (NASDAQ:LFST) Financial Comparison

LifeStance Health Group (NASDAQ:LFST) and Concord Medical Services (NYSE:CCM) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares LifeStance Health Group and Concord Medical Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Concord Medical Services	N/A	N/A	N/A

Risk & Volatility

LifeStance Health Group has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.97, meaning that its stock price is 197% less volatile than the S&P 500.

Institutional & Insider Ownership

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares LifeStance Health Group and Concord Medical Services”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42 billion	3.13	$9.66 million	$0.13	88.46
Concord Medical Services	$65.85 million	0.34	-$13.27 million	N/A	N/A

LifeStance Health Group has higher revenue and earnings than Concord Medical Services.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for LifeStance Health Group and Concord Medical Services, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0	4	6	1	2.73
Concord Medical Services	1	0	0	0	1.00

LifeStance Health Group presently has a consensus price target of $11.62, suggesting a potential upside of 1.09%. Given LifeStance Health Group’s stronger consensus rating and higher probable upside, equities research analysts clearly believe LifeStance Health Group is more favorable than Concord Medical Services.

Summary

LifeStance Health Group beats Concord Medical Services on 12 of the 13 factors compared between the two stocks.

About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.